It 's a race against time as an international pharmaceutical company to develop these life-saving vaccines for the deadly H1N1 influenza virus. The U.S. Food and Drug Administration has only four vaccines for H1N1.
pharmaceutical consulting firm indicated that H1NI vaccines are similar to vaccines against seasonal influenza. The current seasonal flu vaccine will not protect the market against the H1N1 virus.
The FDA continues to playClinical studies to determine the proper dose of vaccine for children. Vaccines are good in clinical trials in adults and side effects similar to seasonal flu vaccine tolerated. FDA studies show that these four vaccines to induce a stronger immune response in healthy adults, eight to ten days after they were vaccinated (similar to the vaccine against seasonal influenza ago).
The FDA is closely linked to the SU Center for Disease Control and othersNon-governmental organizations for further analysis and information exchange. The vaccines will be available by mid-October and about 45 million doses of vaccine available to the public.
The FDA does not all the credit for developing this much needed relief for the H1N1 vaccine. International pharmaceutical companies in Australia, France and Switzerland are important players for the development of the four vaccines.
But the United Statesis not the only country to work hard to develop vaccines for influenza H1N1. Pharmaceutical companies in India report launch in March before its H1N1 vaccine. With the World Health Organization provided funding to the Indian pharmaceutical companies are currently working studies of toxicity in animals and hope to work on clinical trials on humans in December. Your goal is to begin March 1 vaccines in order to stay the course with fellow international pharmaceuticalCompanies.
Although China has already beaten the United States and India and has already started mass vaccination in Beijing. China is the first country in the world to be vaccinated against the H1N1 virus. The health of China to the Bureau with over 500 employees in 50 medical teams from Beijing after already sent to schools to vaccinate students. Vaccination against influenza H1N1 is free and voluntary. Students, teachers and those who suffer from chronic diseases of the lungs and heart are givenfirst priority, get the shots.
China is already hard hit by the virus. Shandong, Guangdong, Hunan and Sichuan is already out of eight provinces, including vaccines delivered. These regions have seen the most severe outbreaks. China has reported that 31 provinces have been affected by the virus. 95 percent of cases of H1N1 in China were broadcast on national and international travelers visiting China.
Australia and Britain are not far behind Chinawhen it comes to presenting their vaccines on the market. Australian pharmaceutical companies begin mass vaccination programs until the end of September. Britain needs to give its 100,000 doses of vaccine in October. The country of Jordan jumps on board and bought two million vaccines by international pharmaceutical companies. Jordan Ministry of Health has reported that the former is a new vaccine in November.
If you liked this article, all sayFriends about it. They will thank you. If you have a blog or a website, you can implement, or (do not forget to mention http://SmartConsultingGroup.com compared to the original source), by post to your website.
No comments:
Post a Comment